These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 15229389)

  • 21. Safety and efficacy evaluation of clopidogrel compared to ticlopidine after stent implantation: an updated meta-analysis.
    Casella G; Ottani F; Pavesi PC; Sangiorgio P; Rubboli A; Galvani M; Fontanelli A; Bracchetti D
    Ital Heart J; 2003 Oct; 4(10):677-84. PubMed ID: 14664280
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A meta-analysis of randomized controlled trials appraising the efficacy and safety of cilostazol after coronary artery stent implantation.
    Jang JS; Jin HY; Seo JS; Yang TH; Kim DK; Kim DS; Kim DK; Seol SH; Kim DI; Cho KI; Kim BH; Park YH; Je HG; Jeong YH; Kim WJ; Lee JY; Lee SW
    Cardiology; 2012; 122(3):133-43. PubMed ID: 22832424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Triple antiplatelet therapy reduces ischemic events after drug-eluting stent implantation: Drug-Eluting stenting followed by Cilostazol treatment REduces Adverse Serious cardiac Events (DECREASE registry).
    Lee SW; Park SW; Yun SC; Kim YH; Park DW; Kim WJ; Lee JY; Lee CW; Hong MK; Kim JJ; Park SJ
    Am Heart J; 2010 Feb; 159(2):284-291.e1. PubMed ID: 20152228
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Meta-analysis of trials comparing oral anticoagulation and aspirin versus dual antiplatelet therapy after coronary stenting. Clues for the management of patients with an indication for long-term anticoagulation undergoing coronary stenting.
    Rubboli A; Milandri M; Castelvetri C; Cosmi B
    Cardiology; 2005; 104(2):101-6. PubMed ID: 16020950
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of triple antiplatelet therapy in obese patients undergoing stent implantation.
    Gao W; Zhang Q; Ge H; Guo Y; Zhou Z
    Angiology; 2013 Oct; 64(7):554-8. PubMed ID: 23359782
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin after coronary stent implantation: 1 and 6-month follow-up.
    Piamsomboon C; Laothavorn P; Chatlaong B; Saguanwong S; Nasawadi C; Tanprasert P; Leelaprute M; Intayakorn U; Amornsak N
    J Med Assoc Thai; 2001 Dec; 84(12):1701-7. PubMed ID: 11999816
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cilostazol-based triple antiplatelet therapy compared to dual antiplatelet therapy in patients with coronary stent implantation: a meta-analysis of 5,821 patients.
    Geng DF; Liu M; Jin DM; Wu W; Deng J; Wang JF
    Cardiology; 2012; 122(3):148-57. PubMed ID: 22832561
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence, mechanism, predictors, and long-term prognosis of late stent malapposition after bare-metal stent implantation.
    Hong MK; Mintz GS; Lee CW; Kim YH; Lee SW; Song JM; Han KH; Kang DH; Song JK; Kim JJ; Park SW; Park SJ
    Circulation; 2004 Feb; 109(7):881-6. PubMed ID: 14967732
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Triple antiplatelet therapy and dual antiplatelet therapy in patients at high risk of restenosis after drug-eluting stent implantation (from the DECLARE-DIABETES and -LONG Trials).
    Lee SW; Chun KJ; Park SW; Kim HS; Kim YH; Yun SC; Kim WJ; Lee JY; Park DW; Lee CW; Hong MK; Rhee KS; Chae JK; Ko JK; Park JH; Lee JH; Choi SW; Jeong JO; Seong IW; Jon S; Cho YH; Lee NH; Kim JH; Park SJ
    Am J Cardiol; 2010 Jan; 105(2):168-73. PubMed ID: 20102913
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term clinical efficacy and safety of adding cilostazol to dual antiplatelet therapy for patients undergoing PCI: a meta-analysis of randomized trials with adjusted indirect comparisons.
    Chen Y; Zhang Y; Tang Y; Huang X; Xie Y
    Curr Med Res Opin; 2014 Jan; 30(1):37-49. PubMed ID: 24083626
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of cilostazol on in-stent neointimal hyperplasia after coronary artery stenting: a quantative coronary angiography and volumetric intravascular ultrasound study.
    Min PK; Jung JH; Ko YG; Choi D; Jang Y; Shim WH
    Circ J; 2007 Nov; 71(11):1685-90. PubMed ID: 17965485
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The efficacy and safety of cilostazol as an alternative to aspirin in Chinese patients with aspirin intolerance after coronary stent implantation: a combined clinical study and computational system pharmacology analysis.
    Xue Y; Feng ZW; Li XY; Hu ZH; Xu Q; Wang Z; Cheng JH; Shi HT; Wang QB; Wu HY; Xie XQ; Lv QZ
    Acta Pharmacol Sin; 2018 Feb; 39(2):205-212. PubMed ID: 28933424
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced antiplatelet therapy after drug-eluting stenting: multicenter Janus Flex carbostent implantation with short dual antiplatelet treatment for 2 or 6 months-MATRIX study.
    Cassese S; De Luca G; Villari B; Berti S; Bellone P; Alfieri A; Montinaro A; Quaranta G; Marraccini P; Piscione F;
    Catheter Cardiovasc Interv; 2012 Sep; 80(3):408-16. PubMed ID: 21735531
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Adding cilostazol to dual antiplatelet therapy achieves greater platelet inhibition than high maintenance dose clopidogrel in patients with acute myocardial infarction: Results of the adjunctive cilostazol versus high maintenance dose clopidogrel in patients with AMI (ACCEL-AMI) study.
    Jeong YH; Hwang JY; Kim IS; Park Y; Hwang SJ; Lee SW; Kwak CH; Park SW
    Circ Cardiovasc Interv; 2010 Feb; 3(1):17-26. PubMed ID: 20118150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of two antiplatelet regimens (aspirin alone versus aspirin + ticlopidine or clopidogrel) after intracoronary implantation of a carbofilm-coated stent.
    Bartorelli AL; Tamburino C; Trabattoni D; Galassi A; Serdoz R; Sheiban I; Piovaccari G; Zimarino M; Benassi A; Di Mario C; Sangiorgio P; Chierchia S; Reimers B;
    Am J Cardiol; 2007 Apr; 99(8):1062-6. PubMed ID: 17437728
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ticlopidine versus oral anticoagulation for coronary stenting.
    Cosmi B; Rubboli A; Castelvetri C; Milandri M
    Cochrane Database Syst Rev; 2001; 2001(4):CD002133. PubMed ID: 11687144
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Randomized comparison of cilostazol vs ticlopidine for antiplatelet therapy after coronary stenting.
    Takeyasu N; Watanabe S; Noguchi Y; Ishikawa K; Fumikura Y; Yamaguchi I
    Circ J; 2005 Jul; 69(7):780-5. PubMed ID: 15988102
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Balloon angioplasty plus cilostazol administration versus primary stenting of small coronary artery disease: final results of COMPASS.
    Tsuchikane E; Takeda Y; Nasu K; Awata N; Kobayashi T
    Catheter Cardiovasc Interv; 2004 Sep; 63(1):44-51. PubMed ID: 15343566
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of cilostazol on late lumen loss and repeat revascularization after Palmaz-Schatz coronary stent implantation.
    Kozuma K; Hara K; Yamasaki M; Morino Y; Ayabe S; Kuroda Y; Tanabe K; Ikari Y; Tamura T
    Am Heart J; 2001 Jan; 141(1):124-30. PubMed ID: 11136497
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Addition of cilostazol to conventional dual antiplatelet therapy reduces the risk of cardiac events and restenosis after drug-eluting stent implantation: a meta-analysis.
    Chen Z; Qian J; Chen Y; Ma J; Ge J
    J Clin Pharmacol; 2013 May; 53(5):532-9. PubMed ID: 23436428
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.